Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Micromedic Technologies

Clinical Trial Research Software Provides Range of Trial Capabilities in Unified Platform

By BiotechDaily International staff writers
Posted on 05 Aug 2013
Print article
New clinical trial software provides end-to-end study support through a single, easy-to-use interface that allows the ability to manage and run studies more effectively. It offers built-in study templates, libraries, and reports to help users create studies rapidly and manage them effectively without technical help.

Merge Healthcare. Inc. (Chicago, IL, USA), a provider of clinical systems, reported that SGS Life Science Services (Geneva, Switzerland) , a contract service organization with over 35 years’ experience in clinical research, has selected Merge’s eClinical OS to streamline data management across phase I-IV studies.

“SGS sought a comprehensive EDC solution that would still be cost-effective for our biotech and smaller pharmaceutical clients,” explained Joris De Bondt, head of EDC and data standards of clinical research at SGS Life Science Services. “More specifically, we needed a system that included interactive response and drug dispensing in addition to data capture functionality. We were pleased to find that Merge’s eClinical OS includes such a broad set of capabilities. Using one system for everything needed maximizes efficiency and improves timelines across all our studies.”

“As one of the premier global CROs in the industry, we’re very pleased to have SGS as a partner,” said Zaher El-Assi, general manager of Merge eClinical. “We find that our CRO partners benefit greatly from training and ongoing support through the Merge Certified Designer program. Our goal is to empower our CRO partners to better serve their customers by developing internal expertise to quickly build, test, and deploy trials for their organization regardless of trial complexity and size.”

“We were most impressed with the ability to tailor the system for each study depending on the features needed. The unique pay-as-you go model provides us with more cost efficiencies that we are then able to pass along to our clients,” explained Mr. De Bondt. “Another benefit was how straight-forward the system was to use. Our team was able to learn the system, build a complete trial and have the trial validated and pass user acceptance testing faster than with previous systems.”

Merge eClinical OS provides end-to-end study support through a single, easy-to-use interface allowing clients to manage and run studies more efficiently than ever before. The system works for the largest and smallest studies, has the flexibility to support trials in any phase, and captures any type of data, from any source, from any modality at any time.

Merge also provides clinical trials software, health stations, and other health data and analytics solutions that engage consumers in their personal health.

SGS Life Science Services is a contract service organization (CSO) providing clinical research, biologics characterization, biosafety, and quality control (QC) testing. SGS provides pharmaceutical companies with phase I-IV clinical trial management services encompassing clinical project management and monitoring, pharmacokinetic/pharmacodynamic (PK/PD) simulation and modeling services, data management, biostatistics, and regulatory consultancy.


Related Links:
Merge Healthcare
SGS Life Science Services


Print article

Channels

Genomics/Proteomics

view channel
Image: Top: Overview of the structure of T-STAR STAR domain in complex with AUUAAA RNA. Bottom left: close up view of the specific recognition of the RNA. Bottom right: close up view of the KH dimerization interface (Photo courtesy of the University of Leicester).

Atomic Structures of Alternative Splicing Regulator Proteins May Lead to New Anticancer Drugs

A detailed structural analysis of two RNA-binding proteins that regulate alternate splicing of gene expression, which can lead to various types of cancer, is expected to aid in the development of drugs... Read more

Drug Discovery

view channel
Image: Naturally occurring clay from Kisameet Bay, Canada, exhibits potent antibacterial activity against multidrug-resistant pathogens (Photo courtesy of Kisameet Glacial Clay Inc.).

Antibiotic Resistant Bacteria Succumb to Treatment with Unique Natural Clay

A team of Canadian medical microbiologists has demonstrated the potential use of a unique type of natural clay for treating pathogenic bacteria that have become resistant to the commonly used antibiotics.... Read more

Business

view channel

Purchase Agreement to Boost Ebola Vaccine Development

A deal to help boost development of a vaccine to protect against Ebolavirus infection was finalized at the recent Davos Conference in Switzerland. Gavi (Geneva, Switzerland), the global alliance for vaccines and immunizations, announced that it would spend five million USD to purchase the Ebola vaccine under development... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.